HLA class I binding prediction via convolutional neural networks
Many biological processes are governed by protein-ligand interactions. One such example is the recognition of self and nonself cells by the immune system. This immune response process is regulated by the major histocompatibility complex (MHC) protein which is encoded by the human leukocyte antigen (HLA) complex. Understanding the binding potential between MHC and peptides can lead to the design of more potent, peptide-based vaccines and immunotherapies for infectious autoimmune diseases. We apply machine learning techniques from the natural language processing (NLP) domain to address the task of MHC-peptide binding prediction. More specifically, we introduce a new distributed representation of amino acids, name HLA-Vec, that can be used for a variety of downstream proteomic machine learning tasks. We then propose a deep convolutional neural network architecture, name HLA-CNN, for the task of HLA class I-peptide binding prediction. Experimental results show combining the new distributed representation with our HLA-CNN architecture achieves state-of-the-art results in the majority of the latest two Immune Epitope Database (IEDB) weekly automated benchmark datasets. We further apply our model to predict binding on the human genome and identify 15 genes with potential for self binding.
Code (1)
Tasks
BIG-bench Machine LearningMHC presentation predictionPredictionSimilar Papers 제목 키워드 기반
A Multi-Label Temporal Convolutional Framework for Transcription Factor Binding Characterization
Transcription factors (TFs) regulate gene expression through complex and co-operative mechanisms. While many TFs act together, the logic underlying TFs binding and their interactions is not fully understood yet. Most cur…
Multi-Label ClassificationBinary ClassificationMulti-Label LearningRanking-based Convolutional Neural Network Models for Peptide-MHC Binding Prediction
T-cell receptors can recognize foreign peptides bound to major histocompatibility complex (MHC) class-I proteins, and thus trigger the adaptive immune response. Therefore, identifying peptides that can bind to MHC class-…
MHC presentation predictionHybrid quantum-classical convolutional neural networks to improve molecular protein binding affinity predictions
One of the main challenges in drug discovery is to find molecules that bind specifically and strongly to their target protein while having minimal binding to other proteins. By predicting binding affinity, it is possible…
Drug DiscoveryQuantum Machine LearningA hybrid quantum-classical fusion neural network to improve protein-ligand binding affinity predictions for drug discovery
The field of drug discovery hinges on the accurate prediction of binding affinity between prospective drug molecules and target proteins, especially when such proteins directly influence disease progression. However, est…
Drug DiscoveryPredictionQuantum Machine LearningDeepDTA: Deep Drug-Target Binding Affinity Prediction
The identification of novel drug-target (DT) interactions is a substantial part of the drug discovery process. Most of the computational methods that have been proposed to predict DT interactions have focused on binary c…
Binary ClassificationDrug DiscoveryPrediction